UNSPSC 51433608: Perhexiline maleate

This classification denotes a calcium channel blocker with the molecular formula C19H35N.C4H4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K7V8Y90G0H, chemically known as 2-(2,2-dicyclohexylethyl)piperidinium hydrogen maleate but more generally known as perhexiline maleate, which bears US NIH Compound Identifier 5284439. European Medicines Agency schedules Perhexiline maleate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03710MIG.

Most nations, for tariff and trade purposes, schedule perhexiline maleate under HS 29333999 and SITC 51574. As of Q4 2014, PERHEXILINE MALEATE remains US FDA's Preferred Term for this commodity. Perhexiline maleate bears US NLM identifiers UMLS ID C0070413 and NCI Concept Code C90822. SMILES: C1CCC(CC1)C(CC2CCCCN2)C3CCCCC3.C(=C\C(=O)O)\C(=O)O.

UNSPSC 51433608 Perhexiline maleate is a Commodity code covering a single pharmaceutical product, but recent state and local activity shows this code is being applied to broader emergency medical and pharmacy procurement activity rather than perhexiline specifically. State and local governments are soliciting emergency medications, generic pharmaceuticals, and over-the-counter products through this classification, with issuers including municipal fire and rescue departments, state health agencies, and cooperative purchasing alliances serving multi-state jurisdictions. The work involves supply of medications to public emergency services and state health benefit programs, with vendors required to meet FDA compliance, Good Manufacturing Practices certification, Drug Supply Chain Security Act standards, expiration and shelf-life requirements, and in some cases OSHA-compliant Safety Data Sheets and accessibility documentation.

Recent activity spans Florida, Texas, and Minnesota. The City of Tampa's Purchasing Department posted an IFB (Bid No. 26P00188) on April 24, 2026, for Advanced Life Support Medications needed by Tampa Fire Rescue, with a response deadline of April 8, 2026 and an estimated contract value of $40,000.00; the solicitation seeks four medication line items with nine-month minimum expiration dates, firm pricing including freight and taxes, and a one-year term with two one-year renewal options. The Texas Health and Human Services Commission issued an RFI (No. HHS0017013) on April 3, 2026, to gather vendor capabilities for direct-to-manufacturer prescription fulfillment outside traditional pharmacy benefit manager and group purchasing organization channels. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, posted an RFP (No. S1070000015802) due March 26, 2026, to establish contracts for generic multi-source pharmaceuticals and OTC products distributed across state and local facilities in Minnesota and Oregon; awarded vendors must work through three authorized wholesalers and comply with 3 percent administrative fees and performance penalties for violations.